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Abstract
Background: Deep brain stimulation has recently been considered a potential therapy in improving memory
function. It has been shown that a change of neurotransmitters has an effect on memory function. However, much
about the exact underlying neural mechanism is not yet completely understood.
We therefore examined changes in neurotransmitter systems and spatial memory caused by stimulation of nucleus
basalis magnocellularis in a rat model of dementia.
Methods: We divided rats into four groups: Normal, Lesion, Implantation, and Stimulation. We used 192 IgG-saporin for
degeneration of basal forebrain cholinergic neuron related with learning and memory and it was injected into all rats
except for the normal group. An electrode was ipsilaterally inserted in the nucleus basalis magnocellularis of all
rats of the implantation and stimulation group, and the stimulation group received the electrical stimulation.
Features were verified by the Morris water maze, immunochemistry and western blotting.
Results: All groups showed similar performances during Morris water maze training. During the probe trial, performance
of the lesion and implantation group decreased. However, the stimulation group showed an equivalent performance to
the normal group. In the lesion and implantation group, expression of glutamate acid decarboxylase65&67 decreased in
the medial prefrontal cortex and expression of glutamate transporters increased in the medial prefrontal cortex
and hippocampus. However, expression of the stimulation group showed similar levels as the normal group.
Conclusion: The results suggest that nucleus basalis magnocellularis stimulation enhances consolidation and retrieval
of visuospatial memory related to changes of glutamate acid decarboxylase65&67 and glutamate transporter.
Keywords: Nucleus basalis magnocellularis, Deep brain stimulation, Spatial memory, Medial prefrontal cortex,
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Background
Alzheimer’s disease (AD) is a progressive and irreversible
neurodegenerative disease accompanied by decline of
memory and cognitive function [1]. Degeneration of cho-
linergic basal forebrain neurons is one of the common fea-
tures of AD [2]. It has been reported that degeneration of
basal forebrain cholinergic neurons (BFCN) and the
decrease of cholinergic projections could be an important
factor characterizing the cognitive decline and functional
impairment that characterizes this disorder [2–4].
As an effective surgical treatment, deep brain stimu-
lation (DBS) has demonstrated its efficacy for the treat-
ment of a variety of movement disorders [5]. Recently,
there is growing evidence from laboratory and clinical
trials that electrical stimulation at memory associated
structures enhances cognitive functions, and DBS has
increasingly been considered as a potential therapy be-
cause of its recent effects in improving memory function
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[6, 7]. However, there is currently limited evidence at best
that DBS improves memory functioning in humans.
Stimulation of the entorhinal region in patients with de-
mentia could improve patient’s spatial memory perform-
ance [8]. In addition, electrical stimulation of the fornix
affects hippocampus-dependent memory [9]. Although
DBS is being evaluated as a promising therapy for dis-
eases related to memory impairment, much about the
underlying exact neural mechanism of DBS is not yet
completely understood. Therefore, studies are needed
to characterize not only the effective regions and stimu-
lation parameters for DBS causing memory improve-
ment, but also the mechanisms connecting memory
enhancement and changes of the neural circuit caused
by stimulation.
In this study, we used 192 IgG-saporin for degener-
ation of BFCN to make a memory impaired rat model
mimicking cholinergic denervation of AD. Composed
of a monoclonal antibody, 192 IgG-sapoin, has a low af-
finity for the rat nerve growth factor receptor p75 lo-
cated on cholinergic cell bodies of the basal forebrain.
And it contains a ribosomal inactivating protein called
saporin [10–12]. Therefore, 192 IgG-saporin injection
to the intraventricular cause selective degeneration of
BFCN closely related with spatial learning and memory
[13, 14].
Nucleus basalis magnocellularis (NBM) in the basal
forebrain has mostly cholinergic neurons, and also it has a
few of noncholinergic neurons such as GABAergic and
glutamatergic [15]. It has mainly projections to the neo-
cortex, amygdala, and thalamus [16, 17]. Substantial evi-
dence suggests that the NBM plays an important role in
neural activities such as learning and memory [11, 16, 18].
NBM lesions by ibotanic acid resulted in deficits in the ac-
quisition of spatial memory tasks, and produced a pro-
found selective disturbance in recent memory [19, 20].
Meanwhile, a research on a two-way active avoidance task
(a test of associative memory) suggests the stimulation of
NBM can improve the acquisition memory [21, 22]. Espe-
cially, the high frequency stimulation by regulating neuro-
transmitters improves memory function. A study suggests
that high frequency stimulation in the dorsal striatum is
effects on response learning and on GABA levels [23].
And also, NBM stimulation in patients with Parkinson-
dementia syndrome caused improvement of cognitive
function [7]. In the present study, we examined whether
unilateral electrical stimulation of the NBM improves
memory in a rat model that mimicking the basal forebrain
cholinergic deficits of AD.
Methods
Animals
All experiments were conducted according to the guide-
lines of the Institutional Animal Care and Use Committee
of Yonsei University and Institute of Laboratory Anima
Resources commission on Life Sciences National Research
Council, USA. This study received approval of Institu-
tional Animal Care and Use Committee (IACUC number:
2014-0206). Every effort was made to minimize animal
suffering and to reduce the number of rats used. Twenty-
five male Sprague–Dawley rats were used that weighed
190 − 210 g (6 week old) at the beginning of the studies.
They were housed in clear plastic cages in a temperature-
and humidity-controlled room with a 12-h light/12-h dark
cycle. Rats were randomly assigned to one of four experi-
mental groups before surgery. The normal group (n = 6)
underwent no surgical procedures. The lesion group
(n = 7) had intraventricular administration of 192 IgG-
saporin. The implantation group (n = 7) and stimula-
tion group (n = 5) had intraventricular administration
of 192 IgG-saporin and implantation of an electrode in
the NBM. The stimulation group had unilateral elec-
trical stimulation.
Administration of 192 IgG-saporin
Rats in the three experimental groups, but not the nor-
mal group, were anesthetized with a mixture of ketamine
(75 mg/kg), acepromazine (0.75 mg/kg), and xylazine
(4 mg/kg), and secured in a stereotaxic frame. Eight mi-
croliters (0.63 μg/μl) of 192 IgG-saporin (Chemicon,
Temecula, CA, USA) were bilaterally injected into the
lateral ventricle following coordinates relating to Bregma
(AP - 0.8 mm, ML ± 1.2 mm, DV - 3.4 mm). The solu-
tions were delivered at a rate of 1 μl/min and diffused
for 5 min after each injection.
Electrode implantation
Right after the administration of 192 IgG-saporin, an
electrode (SNEX-100, contact diameter 0.1 mm, shaft
diameter 0.25 mm, impedance 0.7–1.5 MΩ; David Kopf
Instruments, Tujunga, CA, USA) was inserted into the
right NBM following coordinates relating to Bregma
(AP -1.32 mm, ML + 2.8 mm, DV -7.4 mm) of the rats
in the implantation and stimulation group. Dental ce-
ment (Long Dental Manufacturing, Wheeling, IL, USA)
was used to firmly fix the electrode in place to the skull
surface.
Electrical stimulation
The stimuli were bipolar and electrical stimuli (120 Hz,
90 μs, 1 V) delivered via a Grass A-300 pulsemaster
(Grass Instrument, Quincy, MA, USA). Stimulation pa-
rameters were monitored in real time at the beginning
and end of stimulation using an oscilloscope (HDS
1022 M, Owon, Korea). Rats were unilaterally stimulated
daily beginning one week after surgery until the start of
behavioral testing (1 h per day, 1 week in total).
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Morris water maze (MWM)
The MWM test began 2 weeks after surgery. The test
consisted of 5 consecutive days of training trials and
1 day of a probe trial. A circular dark water maze tank
(2 m diameter, 50 cm deep) located in a dimly lit room,
was filled to a depth of 40 cm with water (maintained at
25 °C). A circular escape platform (15 cm diameter) was
submerged 2 cm below the water surface. In the training
trials, rats were given four acquisition trials per day with
four different starting positions that were equally distrib-
uted around the perimeter of the maze. The test re-
quired the rats to swim to the hidden platform guided
by distal spatial cues. Throughout acquisition, the plat-
form was located in a fixed position in the center of the
southwest quadrant of the pool. For each trial, rats were
released randomly from each of the four cardinal points
from the edge of the pool and gently released facing the
wall. Rats were given a maximum of 60 s to find the
platform. After finding the platform, rats were allowed
to remain on the platform for 10 s and placed in their
home cages. Animals failing to find the platform in 60 s
were guided by an experimenter, then placed on the
platform, and allowed to rest for 10 s. After completion
of training, rats were returned to their home cages for
2 days until the probe trial. The probe trial consisted of
a 60 s free swim period without a platform, during
which the time spent in the target quadrant and the
number of platform crossings was recorded.
Choline acetyltransferase (ChAT) immunohistochemistry
After behavioral testing, three out of six rats from the
normal group, three out of the seven rats from the lesion
group, three out of seven rats from the implantation
group, two out of five rats from the simulation group
were perfused with cold 4 % paraformaldehyde in phos-
phate buffer saline (pH 7.2). Their brains were removed,
post-fixed, and transferred to 30 % sucrose. The brains
were cut into 30 μm coronal sections using a freezing
microtome. The cryoprotection solution consisted of
0.1 M phosphate buffer (pH 7.2), 30 % sucrose, 1 %
polyvinylpyrrolidone, and 30 % ethylene glycol. Tissue
was stained with cresyl violet to confirm correct place-
ment of the needle tracks. To detect cholinergic cells,
tissue was immunohistochemically processed using
polyclonal antibodies against choline acetyltransferase
(ChAT; 1:100; cat# AB144P, Chemicon). The sections
were stained using the avidin-biotin complex method
(Vector Labs, Burlingame, CA, USA) with diaminobenzi-
dinetetrahydrochloride as the substrate. Also fluorescence
immunohistochemistry was performed with ChAT pri-
mary antibody (1:50; cat# AB144P, Chemicon) and Texas
Red (1:400; cat# ab6883, abcam). Anatomical landmarks
from a stereotaxic atlas [24] were used to localize the
medial septum (MS).
Acetylcholinesterase (AChE) assay
Three out of six rats from the normal group, four out
of the seven rats from the lesion group, four out of
seven rats from the implantation group, three out of
five rats from the simulation group were decapitated
with a guillotine, and their brains were quickly removed
to acquire protein for AChE assay and Western blot.
The medial prefrontal cortex and hippocampus were
dissected with fine forceps from 1 mm thick coronal
brain slices. The samples were homogenized in lysis
buffer (Intron, Seongnam, Korea) and centrifuged for
10 min at 12,000 rpm, and the protein in the super-
natant was measured using the bicinchoninic acid pro-
tein assay reagent kit (Pierce, Rockford, IL, USA). The
enzymatic activity of AChE was determined using the
method of Ellman et al. [25] with some modifications.
Twenty microliter triplicate samples identical to those
used in western blot analyses were mixed with a reac-
tion mixture [0.2 mM dithiobisnitrobenzoic acid (Sigma-
Aldrich, St. Louis, MO, USA), 0.56 mM acetylthiocholine
iodide (Sigma-Aldrich), 10 μM tetraisopropylpyropho-
sphoramide (Sigma-Aldrich), 39 mM phosphate buffer;
pH 7.2] at 37 °C. After 30 min, the optical density was
measured at 405 nm.
Western blot
To acquire western blot data, proteins were separated
using a 10 − 15 % sodium dodecyl sulfate-polyacrylamide
gel and transferred onto polyvinylidene fluoride mem-
branes. The membranes were incubated with blocking
buffer [5 % nonfat dry milk in phosphate-buffered saline
containing 0.05 % Tween-20 (PBST)] for 1 h at room
temperature. They were then incubated with the indi-
cated antibodies overnight at 4 °C and washed three
times with PBST. The membranes were incubated with
corresponding secondary antibodies for 1 h at room
temperature. After washing with PBST, proteins were
detected with enhanced chemiluminescence solution
(Pierce) and LAS-4000 (Fujifilm, Tokyo, Japan). The in-
tensity of each band was determined using an analysis
system (Multi Gauge version 3.0, Fujifilm, Tokyo, Japan).
The membranes were incubated with antibodies to glu-
tamate acid decarboxylase 65/67 (GAD 65&67) (1:500;
Millipore, Temecula, CA, USA), glutamate transporter
(GT) (1:4000; Abcam, Cambridge, UK), and β-actin
(1:1000; Sigma-Aldrich).
Statistical analysis
The results of all experiments were expressed as a per-
centage of the values for the normal group. The results
of the western blots were normalized to β-actin for each
sample and expressed as a percentage of the normal
values. One-way ANOVA was used for overall analysis
of experiments. ANOVA followed by least significant
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difference was used as a post hoc test at each time
point for statistical analysis. The p values less than 0.05
were considered statistically significant. All statistical
analyses were performed by PASW (version 18; SPSS
Inc., Chicago, IL, USA).
Results
The location of MS and degeneration of
ChAT-immunopositive neurons by 192 IgG-saporin
Figure 1a and b shows the location of MS in the atlas [24]
and in a brain slice stained with cresyl violet. The 192
IgG-saporin injections produced denervation of ChAT-
immunopositive neurons in the MS (Fig. 1). In normal
rats (C), the ChAT-immunopositive neurons were evenly
distributed in the MS. By contrast, lesion (D), implant-
ation (E), and stimulation (F) groups showed a remarkable
decrease. The number of ChAT-immunopositive cells
of the normal group was 125 ± 10.11. However, it was
significantly decreased by administration of 192 IgG-
saporin (lesion group, 18.3 ± 3.3; implantation group,
25 ± 4.5; stimulation group, 28 ± 5.6). In addition, 192
IgG-saporin damaged ChAT-immunopositive cells in
the NBM (Fig. 2). The normal group (A) averagely had
47 ± 6.2 ChAT positive cells whereas 192 IgG-saporin
injection groups (lesion, B; implantation, C; stimulation,
D) remarkably decreased ChAT positive cells (lesion
group, 26 ± 4.0; implantation group, 25.5 ± 6.4; stimula-
tion group, 21.1 ± 6.8).
Confirmation of the location of the electrode in the NBM
We confirmed the location of the inserted electrode in
the NBM using cresyl violet staining. Figure 3a shows
the location of NBM in a atlas. And also, Fig. 3b and c
shows the location of NBM in the implantation and
stimulation group, respectively. Although the electrodes
were very close to the pallidum and internal capsule,
there were no side effects such as seizure, abnormal
C D
E F
A B
Fig. 1 Representative photographs are showing the location of MS and the effect of cholinergic lesions on the MS. Figure (a) shows the location
of MS in Atlas [24] and Figure (b) shows the location of MS in a brain slice stained with cresyl violet. The normal group had numerous
ChAT-immunopositive neurons (c). The lesion (d), implantation (e), and stimulation (f) groups show a loss of cholinergic neurons. Scale bar
represents 500 μm
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behavior when we implant the electrodes and stimulate
the nucleus basalis.
The performances of all groups in the MWM
On the last day of training trials, all groups found the
platform in 20 s, which was evidence of learning the
platform location (Fig. 4a). During the probe trial, all
groups showed similar motor-related behaviors, evi-
denced by equivalent swim distances and speeds.
These findings suggest no effect of cholinergic lesion,
electrode implantation, or electrical stimulation on
motor function (Fig. 4b). Compared to the normal
group, the lesion (no implantation) group showed less
time in the target quadrant, less time in the platform
zone, and fewer platform crossings (*p < 0.05). The
stimulation group showed similar performance as
compared with the normal group in terms of time
spent in the target quadrant and number of platform
crossings. Notably, there were statistically significant
differences between the implantation and stimulation
group in time on the platform zones and platform
crossings (+p < 0.05).
AChE activity in the medial prefrontal cortex (mPFC) and
the hippocampus
There were no significant differences of AChE activity in
the mPFC among groups (Fig. 5a). In addition, there
were no differences among groups in AChE activity in
the hippocampus, except for the normal group (Fig. 5b).
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Fig. 2 Representative photographs showing ChAT-immunopositive
neurons in the NBM. Numerous ChAT-immunopositive neurons (red) were
showing in the normal group (a). However, cholinergic neurons were
significantly damaged by 192 IgG-saporin (lesion group, b; implantation
group, c; stimulation group, d) The number of ChAT-immunopositive
cells were significantly decreased in lesion, implantation and stimulation
group compared with normal group (e).
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C
Fig. 3 The location of the NBM in the rat brain atlas (a) and in a
brain slice stained with cresyl violet in implantation (b) and
stimulation group (c). The rectangles black box designates the
insertion track of the electrode
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Fig. 4 Spatial memory performance during training trials (a) and the probe trial (b) in the MWM. The 5 days of training trial, the latency to
find platform gradually decreased (a). And the percentage of stimulation group to find platform is significantly higher than lesion and
implantation group (b)
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Fig. 5 AChE activity in the mPFC (a) and hippocampus (b). Indices are expressed as the percentage of normal group values (mean ± standard
error of the mean)
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The expressions of GAD 65&67 and GT in the mPFC
and hippocampus
In the mPFC, expression of GAD 65&67 in the lesion
and lesion-implantation groups was decreased com-
pared with the normal group. However, the stimulation
group showed a similar level as the normal group
(Fig. 6a). In the hippocampus, the expression level of
GAD 65/67 was decreased to 25.32 % in animals receiv-
ing DBS. However, there were no significant differences
of GAD65&67 expressions among groups in the hippo-
campus (Fig. 6c). The lesion and implantation groups
showed a significant increase in expression of GT both in
the mPFC and hippocampus (Fig. 6b and d) (*p < 0.05).
However, the stimulation group showed a similar GT
expression as compared to the normal group in the
both regions. And also, the stimulation group showed
notably decreased expression of GT both mPFC and
hippocampus as compared with the implantation group
(Fig. 6b and d) (+p < 0.05).
Discussion
The results of the present study showed improved
spatial memory performance in the MWM after stimu-
lation of the NBM, suggesting that stimulation of the
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Fig. 6 The expression of GAD65&67 and GT in the mPFC and hippocampus. The expression of GAD65&67 (a) and GT (b) in the mPFC. The expression
of GAD65&67 (c) and GT (d) in the hippocampus (d). Unlike the lesion and implantation group, the stimulation group showed a similar percentage as
compared to the normal group except for the expression of GAD65&67 in the hippocampus. The results of the western blots analyses were
normalized to β-actin for each sample and expressed as a percentage of normal group values
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NBM affects enhancement of visuospatial memory. Our
results support a recent clinical study which reported
slight improvement or stabilization of AD-associated
symptoms by NBM-DBS [26]. In addition, we examined
changes of GAD 65&67 and GT expression after stimu-
lation of the NBM, which showed that NBM regulates
changes of the GABA (Gamma-Amino Butyric Acid)
and glutamate systems.
The interactions between the mPFC and hippocampus
are essential for learning and memory of a visuospatial
memory test such as the MWM [27]. A previous study
reported that functional disconnection between the
mPFC and hippocampus impaired spatial working mem-
ory in rats [28]. Therefore, interaction between the two
structures is necessary [29]. The mPFC is essential for
consolidation and retrieval, and the hippocampus is cru-
cial for the acquisition in MWM [27, 30–33]. In this
study, there were differences among groups in the probe
trial in the MWM but not in the training trial. Taken to-
gether, the results show that mPFC is more affected than
the hippocampus by stimulation of the NBM.
GABA is closely involved in memory function [34, 35].
Injections of the GABA blocker picrotoxin may interfere
with consolidation [36], and an increase of GABA by
chemotherapy might enhance the learning ability of re-
tarded or emotionally disturbed children [37]. Reduced
GABA activity by cholinergic lesion was increased by
NBM stimulation to a similar level as the normal group
in the mPFC in this study. Previous studies suggested
that GABA is more closely involved in memory consoli-
dation and retrieval phases than the memory acquisition
phase, and suggested that GABA is engaged in earlier
period of consolidation, whereas acetylcholine (Ach) af-
fects relatively remote period of memory consolidation
in septo-hippocampal [38]. The results of this study
showed a memory deficit by decreasing GAD level after
lesion by 192-IgG saporin, and memory enhancement by
increasing GAD level after NBM stimulation. The GAD
level changed by NBM stimulation seems to cause im-
provement of recent retention memory in the mPFC
that is known to be involved consolidation and retrieval
during probe test of MWM test. Actually, some studies
suggest that NBM stimulation may also activate neuro-
transmitter systems such as γ-aminobutyric acid neurons
that send projections to the cortex [39, 40].
It is known that denervation of BFCN by 192 IgG-
saporin increases glutamatergic response in the hippo-
campus [41]. Glutamate transporters of glial cell allow
neighboring synapses to operate more independently,
and control the postsynaptic response to high fre-
quency bursts of action potentials [42]. In this study,
NBM stimulation reduced GT overexpression by lesions
to a similar level as the normal group, which seemed to
have an effect on the spatial memory. However, there
should be further studies to understand the exact mecha-
nisms of this process.
Ach is regarded as an essential factor for memory pro-
cessing and cognitive functioning [43, 44]. We showed
spatial memory improvement, although there were no
changes of AchE activity in the mPFC and hippocampus
after stimulation. Ach is mainly associated with the
memory that is involved relatively remote period. In a
study, the cholinergic lesioned group maintained their
consolidation memory in until after 5 day, while the
GABAergic lesioned group did not maintained their
memory until 5 day in MWM [38]. The MWM in this
study includes relatively recent retention periods. There-
fore, the spatial memory improvement in the present
study may have been affected by other factors rather
than Ach. However, unless we directly confirm the
change in the amount of acetylcholine, cholinergic ef-
fects seems not be excluded. In addition, the effects of
cholinergic neurons which remained in the stimulation
site could not be excluded.
Conclusions
NBM stimulation enhances consolidation and retrieval
of visuospatial memory related to changes of GAD and
GT level in the mPFC. However, it is unclear how elec-
trical stimulation affects changes of the neurotransmitter
system, and how the changes are involved in visuospatial
memory. Therefore, future studies need to examine the
exact mechanisms connecting electrical stimulation and
the various neurotransmitter systems.
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